Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose and Multiple-Ascending Dose Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

NCT06945419 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT06945419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06945419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose and Multiple-Ascending Dose Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
April 23, 2025
Completion date
August 5, 2026
Enrollment
219 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, obesity, overweight, type 2 diabetes